SLDB FY 2019 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena

SLDBSolid Biosciences Inc.

$581M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3M

Operating Income

-$119M

Net Income

-$117M

EPS (Diluted)

$-43.05

Cash Flow

Operating Cash Flow

-$93M

Free Cash Flow

-$97M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$103M

Total Liabilities

$23M

Stockholders' Equity

$80M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3M	-$2M	-80.3%
Operating Income	-$119M	-$76M	-57.6%
Net Income	-$117M	-$75M	-56.7%